Related Experiment Video

Updated: Aug 23, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

[TGF-beta signaling pathway in pancreatic cancer cells]

Hideaki Ijichi1

  • 1Department of Gastroenterology, Graduate School of Medicine, University of Tokyo.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 31, 2004
PubMed

Insights

Transforming growth factor-beta (TGF-beta) plays a dual role in pancreatic cancer. Investigating TGF-beta signaling in Smad4-inactivated cells is crucial for identifying new therapeutic targets.

Area of Science:

  • Molecular biology
  • Oncology
  • Cell signaling

Context:

  • Transforming growth factor-beta (TGF-beta) is a cytokine regulating crucial cellular processes like growth, differentiation, and immune response.
  • The Smad pathway is the primary mediator of TGF-beta signaling, typically inhibiting epithelial cell growth.
  • Pancreatic cancer frequently involves Smad4/DPC4 gene mutations, correlating with invasive and metastatic phenotypes.

Purpose:

  • To investigate the role of TGF-beta signaling in pancreatic cancer, particularly in the context of Smad4 inactivation.
  • To identify genes and pathways regulated by TGF-beta in Smad4-deficient pancreatic cancer cells.
  • To explore potential therapeutic targets for pancreatic cancer based on TGF-beta signaling.

Summary:

  • TGF-beta, a multifunctional cytokine, signals primarily through the Smad pathway to inhibit epithelial cell growth.
  • Smad4 gene alterations are common in pancreatic cancer, associated with increased invasiveness.
  • In Smad4-inactivated pancreatic cancer cells, TGF-beta signaling influences genes involved in both tumor suppression and progression, highlighting its complex role.

Impact:

  • Understanding TGF-beta's dual role in pancreatic cancer progression is essential.
  • Identifying specific genes and pathways regulated by TGF-beta in Smad4-mutated cancers can lead to novel therapeutic strategies.
  • This research aims to uncover effective molecular targets for treating pancreatic cancer.

More Related Videos

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture03:42

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture

Published on: September 27, 2024

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...